Norwegian Cruise Line Hlgs Ltd. (NCLH)
| Sector: | Services |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.106% |
| Hold Price * : | $18.70 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q4  2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 100,561 | 0.03 | |
| Q3  2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 3.05% | 143,708 | 0.14 | |
| ≡ | John Rogers - Ariel Investments | Reduce 2.30% | 285,085 | 0.08 | |
| Q2  2025 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 287,337 | 0.10 | |
| Q4  2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 11.35% | 318,141 | 0.38 | |
| ≡ | John Rogers - Ariel Investments | Reduce 24.74% | 1,315,769 | 0.36 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 70.08% | 239,525 | 0.12 | |
| Q3  2024 | |||||
| ≡ | John Rogers - Ariel Investments | Reduce 6.37% | 361,868 | 0.08 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 1.24% | 35,058 | 0.04 | |
| Q2  2024 | |||||
| ≡ | John Rogers - Ariel Investments | Reduce 2.89% | 169,141 | 0.03 | |
| Q1  2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 4.75% | 120,325 | 0.12 | |
| Q4  2023 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.04% | 1,012 | 0.00 | |
| Q3  2023 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 18.20% | 563,997 | 0.55 | |
| Q2  2023 | |||||
| ≡ | Bill Miller - Miller Value Partners | Sell 100.00% | 3,547,135 | 2.98 | |
| Q1  2023 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 6.75% | 256,848 | 0.22 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 1.69% | 8,500 | 0.05 | |
| Q4  2022 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 7.57% | 311,524 | 0.25 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 209,495 | 0.05 | |
| Q3  2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 23.08% | 62,842 | 0.01 | |
| Q2  2022 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 12.25% | 570,232 | 0.35 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 7.30% | 35,850 | 0.20 | |
| Q1  2022 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 3.48% | 17,700 | 0.15 | |
| Q4  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 69,960 | 0.02 | |
| Q3  2021 | |||||
| ≡ | Bill Miller - Miller Value Partners | Reduce 9.83% | 392,239 | 0.36 | |
| Q2  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 54 | 0.00 | |
| Q3  2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 55,023 | 0.02 | |
| Q1  2020 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Sell 100.00% | 133,000 | 1.20 | |
| Q4  2017 | |||||
| ≡ | Leon Cooperman | Sell 100.00% | 125,000 | 0.26 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.